The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
January 22nd 2025
Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.
Fauci: DSMB Challenge of New AstraZeneca COVID-19 Vaccine Data Is an ‘Unfortunate Incident’
March 23rd 2021Following a review of the latest interim data released by AstraZeneca on its US phase 3 clinical trial assessing the 2-dose AZD1222 COVID-19 vaccine, the Data and Safety Monitoring Board (DSMB) expressed concern at the inclusion of what may have been outdated data.
Read More
Phase 3 Trial of Adjuvanted COVID-19 Vaccine Candidate Commences Enrollment in the US, Canada
March 23rd 2021Phase 3 clinical testing of a plant-derived COVID-19 vaccine candidate in combination with a pandemic adjuvant commenced following approval to proceed with participant enrollment from regulatory authorities in both Canada and the United States.
Read More
Exposure to Common Preservative During Pregnancy May Increase Breast Cancer Risk
March 23rd 2021Low doses of propylparaben–a chemical preservative found in food, drugs, and cosmetics–can alter pregnancy-related changes in the breast in ways that may lessen the protection against breast cancer normally conveyed by pregnancy hormones.
Read More
Study: Dogs Could Provide Greater Service for Prostate Cancer Screenings
March 22nd 2021Clinicians have been searching for accurate, reliable, non-invasive diagnostic tools to differentiate early stage, less dangerous, and more treatable stages of the disease from the aggressive, high-grade and likely-to-spread forms.
Read More
Clinical Trial Confirms Nasal Spray Efficacy in Treating, Reducing Transmission of COVID-19
March 18th 2021Results of clinical trials have shown that a nitric oxide nasal spray is both a safe and effective antiviral treatment to prevent COVID-19 transmission and symptom duration, as well as reduce symptom severity and damage in those already infected.
Read More
FDA Grants MK-6482 NDA Priority Review for von Hippel-Lindau Disease-Associated RCC
March 17th 2021The FDA has granted priority review for an NDA for the hypoxia-inducible factor-2 alpha inhibitor MK-6482 for the potential treatment of patients with von Hippel-Lindau disease-associated renal cell carcinoma that does not require immediate surgery.
Read More
Webcast: The Impact of the Federal Retail Pharmacy Program on COVID-19 Vaccinations and Pharmacists
March 16th 2021Following the establishment of the Federal Retail Pharmacy Program by the CDC, a panel of experts sat down with Pharmacy Times® to address the implications of the Federal Retail Pharmacy Program for COVID-19 vaccinations.
Watch
Opioid Epidemic Linked to Greater Number of Heart Infections in the US
March 16th 2021Preliminary research by the American Heart Association suggests the opioid epidemic in the United States may have led to an increase in the number of strokes due to bacterial infections of the heart (infective endocarditis).
Read More
Hospital Pharmacies Must Innovate to Drive Financial Recovery
March 12th 2021The pharmaceutical supply chain, while always central to health care, will play an even more crucial role as the pandemic continues to threaten the financial viability of hospitals and health systems, large and small.
Read More